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We examined the response of rat female pituitary at diﬀerent metabolic stages to treatments with estrogenic compounds and
vitamin D analogs. Immature or ovariectomized (Ovx) female rats responded by increased creatine kinase speciﬁc activity (CK)
to estradiol-17β (E2), genistein (G), daidzein (D), biochainin A (BA), quecertin (Qu), carboxy- G (cG), carboxy- BA (cBA), and
raloxifene (Ral). The response was inhibited when Ral was injected together with the estrogens. CK was increased when hormones
were injected daily into Ovx rats for 4 diﬀerent time periods. Pretreatment with the less-calcemic vitamin D analogs JK 1624
F2-2 (JKF) or QW 1624 F2-2 (QW) followed by estrogenic injection resulted in increased response and sensitivity to E2 and loss
of inhibition of E2 by Ral. CK was also increased by feeding with E2 or licorice or its components dose- and time- dependent in
immatureorOvxrats.DiabeticfemaleratsdidnotrespondtoincreaseddosesofE2.Inconclusion,ratfemalepituitaryisestrogens-
responsiveorgan,suggestingtoconsideritsresponseforHRTinpostmenopausalwomenforbothbeneﬁcialandhazardousaspects.
Copyright © 2009 D. Somjen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Estradiol-17β (E2) is essential for all aspects of reproductive
function in females through activation of estrogen receptors
(ERs). In the rat E2 stimulates basal secretion of pituitary
reproductive hormones [1]. The pituitary expresses both
estrogen receptors, ERα and ERβ [2], and it responds to both
ERα speciﬁc and ERβ speciﬁc agonists [33]. E2 was found
to have pleiotropic eﬀects on physiological function in rat
pituitary [3].
Phytoestrogens are plant-based estrogenic compounds,
which are selective estrogen receptor modulators (SERMs)
due to their ability to induce both agonistic and antag-
onistic eﬀects. There is a growing interest in the use of
phytoestrogens in Western countries. Widely marketed as
food additives and present at fairly high concentrations in
soy products [4, 5], phytoestrogens are commonly treated
in the lay media as a uniform class of naturally occurring
estrogenic compounds retaining the beneﬁcial eﬀects of
estrogensbutcarryingnoneoftheharmspotentiallyinﬂicted
by native or synthetic estrogens. However, phytoestrogens
vary considerably in terms of structure, estrogenic potency,
and availability in common food sources such as soybeans,
cereals, and sprouts [5]. Most human dietary sources contain
phytoestrogens of two major chemical classes, isoﬂavones
and lignans. The isoﬂavone genistein (G) is perhaps the best
studied phytoestrogen [5–7] whereas data on the biological
eﬀects of other common isoﬂavones such as daidzein (D)
or its metabolite equol [5–7] are relatively scarce. Based
on favorable eﬀects of these compounds on lipid oxidation
[8, 9] and vascular reactivity [5] ,ar e c e n tr e v i e wo fl i t e r a t u r e
suggested that dietary phytoestrogen consumption may
confer cardiovascular protection [6]. Phytoestrogens in the
diet were also found to aﬀect pituitary of rats, by modulating
serum gonadotropin levels [10] similar to E2.
Licorice root extract (L) and its major isoﬂavans,
glabridin(Gla)andglabrene(Glb),exhibitedvaryingdegrees
of ERs’ agonism in diﬀerent tissues in vivo. Animals fed2 International Journal of Cell Biology
with L, Gla, and Glb similar to E2 showed increased CK in
diﬀerent organs [11, 12]. Phytoestrogens fed to rats were also
found to alter some neurobehavioral eﬀects [13] similar to
E2.
Vitamin D binding protein is expressed in rat hypotha-
lamus which shows its biological activity [14]. Vitamin D
receptors(VDR)arealsoexpressedinthehypothalamus[15]
as well as in human pituitary [16] and in rat pituitary [17–
19].
E2 regulates a spectrum of activities in the pituitary as
well as induction of calbindin D9K in the rat [20]w h i c hi s
also regulated by vitamin D metabolite 1,25(OH)2D3 [21].
We have previously studied the hormonal modulations
in diﬀerent systems of the speciﬁc activity of the “estrogen-
induced protein” creatine kinase BB [22], a rapid estrogen
response-marker.
The present study was undertaken to see if, due to the
presence of both E2 and vitamin D receptors, the pituitary
of female rats responds by induction of CK, to diﬀerent
hormones such as E2 and diﬀerent phytoestrogens with
and without pretreatment with the less-calcemic vitamin D
analogs JKF and QW by diﬀerent ways of application and
at diﬀerent physiological status. The obtained results might
suggest considering also the response of the pituitary to
hormonal treatment, such as hormone replacement therapy
(HRT) for postmenopausal women, is used for both its
beneﬁcial and its hazardous aspects.
2.MaterialsandMethods
Rats. (1) Wistar-derived prepubertal female rats, aged 25
days weighing 60g at the start of the experiment (intact) or 2
weeks postovariectomy (Ovx), were used. Intact or Ovx rats
were injected daily (5 days per week) for 10 weeks with either
E2 (5μg / r a t ) ,R a l ,G ,c G ,c B A ,B A ,o rD( a l la t5 0 0μg/rat),
or raloxifene (Ral 500μg/rat) or all hormones with Ral, or
all pytoestrogens together with E2. In other experiments,
licorice (L, 25μg/rat), or its synthetic derivatives glabridine
(Gla, 25μg/rat) or glabrene (Glb 25μg/rat) with and without
E2 or Ral was given to rats by feeding for diﬀerent time
periods. The doses used were found in previous studies, to
be the optimal eﬀective doses in this model.
(2) Sprague Dawley female rats, at the age of 5 weeks,
weighing 120g, was injected subcutaneously with a single
dose of Streptozotocin (STZ; 60mg/Kg BW in 0.05M citrate
buﬀer, pH 5.7). Additional group of animals were injected
with the vehicle (0.05M citrate buﬀer, pH 5.7) and served as
healthy controls. The animals were kept for 8 weeks in cages
with 12 hours cycles of light and dark, Purina chow and tap
water supplemented ad libidum [23]. Rats were used either
a si n t a c to r4w e e k sp o s t o v a r i e c t o m y( O v x ) .E 2 at diﬀerent
doses was injected for 24 hours, followed by harvesting the
pituitary for creatine kinase speciﬁc activity (CK) assay.
(3) For pretreatment with vitamin D less-calcemic
analogs, Wistar-derived rats were used at initial age of 25
days. Female rats were used either as intact or after ovariec-
tomy(Ovx),andtreatmentsstarted2weekspostsurgery.Rats
were injected daily for diﬀerent time periods as indicated
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Figure 1: Stimulation of creatine kinase (CK) speciﬁc activity by
diﬀerent estrogenic compounds in pituitary in immature female
rats (a) and ovariectomized female rats (b). Rats were treated and
assayed for CK activity as described in Section 2. Results are means
± SEM for n = 5–15 rats/group. Experimental means compared to
control means: ∗P<. 05 and ∗∗P<. 01. Basal activity in pituitary
from intact rats was 1.12 + 0.17μmol/min/mg protein and in Ovx
rats was 0.47 +0.02μmol/min/mg protein.
with the analogs JKF 1624F2-2 (JKF) or QW 1624F2-2 (QW)
(0.2ng/grBW),and24hoursafterthelastinjection,ratswere
injected with E2 (0.5μg/rat), raloxifene (Ral) (500μg/rat) or
both followed by harvesting the pituitary for creatine kinase
speciﬁc activity (CK), assay.
Creatine Kinase Speciﬁc Activity Preparation and Assay. Rat
pituitary was collected and homogenized in cold isotonic
extraction buﬀer using a Polytron homogenizer. Enzyme
extracts were obtained by centrifugation of homogenates at
14000×gf o r5m i n u t e sa t4 ◦C. CK speciﬁc activity was mea-
sured in a Kontron Model 922 Uvicon Spectrophotometer
using a Sigma coupled assay kit, and protein was assayed by
Coomassie brilliant blue dye binding. Results are means ±
SEM and are expressed as % of control of CK in hormone-
treated compared to vehicle-treated, control animals.
Materials. Estradiol-17β (E2), creatine kinase (CK) assay kit,
and all phytoestrogens used were purchased from Sigma
Chemicals Co. (St. Louis, MO. USA). Raloxifene (Ral) was
donated by Dr. B. Founier, Novartis Basel Switzerland. The
carboxy-derivatives of the phytoestrogens were synthesized
by us [24, 25]. Licorice, glabridin, and glbrene were prepared
by us from the roots of G. glabra [26, 27]. JK 1624 F2-2 (JKF)
and QW 1624F2-2 (QW) were synthesized and provided by
Dr. G. H. Posner, Johns Hopkins University Baltimore MD.
USA [28]. All other reagents used were of analytical grade.International Journal of Cell Biology 3
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Figure 2: Stimulation of creatine kinase (CK) speciﬁc activity
by diﬀerent estrogenic compounds with and without raloxifene
(Ral; cross-hatches bars) in pituitary from immature (a) and from
ovariectomized female rats (Ovx; b). Rats were treated and assayed
for CK activity as described in Section 2. Results are means ±
SEM for n = 5–15 rats/group. Experimental means compared to
control means: ∗P<. 05 and ∗∗P<. 0 1 .B a s a la c t i v i t yi nP if r o m
intact rats was 1.22+0.27μmol/min/mg protein and from Ovx was
0.67+ 0.22μmol/min/mg protein.
Statistical Analysis. Data were calculatedas % stimulation by
the treatment relative to control rats for each experiment as
previously described. Comparison between the control and
various treatments was made by analysis of variance using
ANOVA.
3. Results
Eﬀects of Diﬀerent Estrogenic Compounds on CK Speciﬁc
Activity in Immature and in Ovx Female Rats. When intact
female (a) or Ovx (b) female rats were injected for 24
hours with either E2 (5μg/rat), genistein (G), carboxy-G
(cG), biochainin A (BA), carboxy- BA (cBA) or daidzein (D)
(all at 500μg/rat), glabridin (Gla) (25μg/rat), or glabrene
(Glb)(25μg/rat).AllhormonesthatinducedCKfordiﬀerent
extent in pituitary from both type of animals (Figure 1). Of
note is the fact that most of the hormones were more active
in pituitary from immature rats than in organs from Ovx
rats.
Eﬀects of Diﬀerent Estrogenic Compounds with Raloxifene
on CK Speciﬁc Activity in Immature and in Ovx Female
Rats. Intact or Ovx female rats were injected for 24hours
with either E2 (5μg/rat), genistein (G), carboxy-G (cG),
biochainin A (BA), carboxy- BA (cBA) or daidzein (D) (all
200
100
50
150
0
CG c G
+cG
DB A c B A
+cBA
Qu
Immature
+G +D +BA +Qu
∗∗
∗∗ ∗
∗
∗
∗ ∗ ∗ ∗
∗
∗
Female rats injected for 24 h
E2 E2 E2 E2 E2 E2 E2
C
r
e
a
t
i
n
e
 
k
i
n
a
s
e
 
s
p
e
c
i
f
i
c
a
c
t
i
v
i
t
y
 
(
s
t
i
m
u
l
a
t
i
o
n
 
(
%
)
)
(a)
200
100
50
150
0
Ovx
∗
∗
∗ ∗ ∗ ∗ ∗ ∗ ∗ ∗ ∗
Female rats injected for 24 h
CG c G
+cG
DB A c B A
+cBA
Qu
+G +D +BA +Qu
E2 E2 E2 E2 E2 E2 E2
C
r
e
a
t
i
n
e
 
k
i
n
a
s
e
 
s
p
e
c
i
f
i
c
a
c
t
i
v
i
t
y
 
(
s
t
i
m
u
l
a
t
i
o
n
 
(
%
)
)
(b)
Figure 3: Stimulation of creatine kinase (CK) speciﬁc activity by
diﬀerent estrogenic compounds with and without E2 in pituitary
from immature (a) and from ovariectomized female rats (Ovx;
b). Rats were treated and assayed for CK activity as described in
Section 2. Results are means ± SEM for n = 5–15 rats/group.
Experimental means compared to control means: ∗P<. 05 and
∗∗P<. 01. Basal activity in organs from immature and OVX rats
were1.02+0.15μmol/min/mgproteinand0.67+0.22μmol/min/mg
protein, respectively.
at 500μg/rat), glabridin (Gla) (25μg/rat) or glabrene (Glb)
(25μg/rat) or raloxifene (Ral 500μg/rat) or all hormones
with Ral. All hormones induced CK for diﬀerent extent and
enzyme induction in the pituitary by all compounds except
Glb were inhibited when Ral was injected together with them
(Figure 2).
Eﬀects of Diﬀerent Estrogenic Compounds with and without
Estradiol-17β on CK Speciﬁc Activity in Immature and in Ovx
Female Rats. Intact or Ovx female rats were injected for
24hours with either E2 (5μg/rat), genistein (G), carboxy-G
(cG), biochainin A (BA), carboxy- BA (cBA) or daidzein (D)
(all at 500μg/rat), or all hormones with E2.A l lh o r m o n e s
tested induced CK for diﬀerent extent, but only cG and cBA
wheninjectedtogetherwithE2 inhibitedCKinducedbyeach
of them alone or E2 alone (Figure 3).
Eﬀects of Diﬀerent Estrogenic Compunds Injected Daily for
4M o n t h so nC KS p e c i ﬁ cA c t i v i t yi nO v xF e m a l eR a t s .Ovx
female rats were injected daily for 4 months with either E2
(5μg/rat), genistein (G), biochainin A (BA), carboxy- BA
(cBA) or daidzein (D) (all at 500μg/rat), or raloxifene (Ral
500μg/rat). All hormones tested induced CK for diﬀerent
extents (Figure 4). Maximal stimulation was obtained by4 International Journal of Cell Biology
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Figure 4: Stimulation of creatine kinase (CK) speciﬁc activity by
diﬀerent estrogenic compounds in pituitary from ovariectomized
female rats, injected daily for 4 months. Rats were treated and
assayed for CK activity as described in Section 2. Results are means
± SEM for n = 5–10 rats/group. Experimental means compared
to control means: ∗P<. 05 and ∗∗P<. 01. Basal activity in the
pituitary was 0.87 +0.17μmol/min/mg protein.
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Figure 5: Dose-dependent stimulation of creatine kinase (CK)
speciﬁc activity by licorice, fed daily for 3 days, in pituitary from
immature female rats, compared to feeding with single dose of
E2. Rats were treated and assayed for CK activity as described
in Section 2. Results are means ± SEM for n = 5r a t s / g r o u p .
Experimental means compared to control means: ∗P<. 05 and
∗∗P<. 01. Basal activity was 1.05+ 0.20μmol/min/mg protein.
E2 whereas all other phytoestrogens had lower but similar
eﬀects.
Eﬀects of Licorice Fed into Immature Female Rats at Diﬀerent
Doses on CK Speciﬁc Activity. When intact immature female
rats were fed daily for 3 days with either E2 (5μg/rat) or
licorice (L) at diﬀerent doses (25–200μg/rat), the com-
pounds induced CK dose-dependently (Figure 5). The daily
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Figure 6: Stimulation of creatine kinase (CK) speciﬁc activity
by licorice (L), glabridin (Gla) with and without E2 in pituitary
from immature (a) or from Ovx female rats (b). Rats were fed for
diﬀerent time periods as indicated and assayed for CK activity as
described in Section 2. Results are means ± SEM for n = 5–10
rats/group. Experimental means compared to control means: ∗P<
.05 and ∗∗P<. 01. Basal activity in Pi from immature rats was
0.97 + 0.22μmol/min/mg protein and from Ovx rats was 0.67 +
0.18μmol/min/mg protein.
feeding for 3 days with L was maximal at around 100μg/rat,
and this was similar to the stimulation by E2 at 5μg/rat.
Eﬀects of Licorice or Glabridin or E2 Injected into Immature or
Ovx Female Rats on CK Speciﬁc Activity. When intact or Ovx
female rats were injected with either E2 (5μg/rat), glabridin
(Gla 25μg/rat) or licorice (L 25μg/rat), or E2 together with
G l ao rL ,f o rd i ﬀerent time periods, there was an increase
of CK by all hormonal combinations injected, with no
additivity with the combined treatments at both animal
types (Figure 6). In both animal types most of the eﬀects
were time-dependent with increased response at the longer
time period measured. When Ovx female rats were injected
daily for 4 weeks with either E2 (5μg/rat), glabrene (Glb
25μg/rat) or E2 together with Glb, all hormones induced CK
for diﬀerent extent, and when injected together with E2,C K
induction by E2 was inhibited by Glb (data not shown).
Eﬀects of Diﬀerent Doses of Estradiol-17β for 24 hours on CK
Speciﬁc Activity in Immature Female Rats Either Intact Or
Diabetic. In intact or Ovx female rats either at their normal
or diabetic stage injected for 24 hours with E2 (5μg/rat), CKInternational Journal of Cell Biology 5
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Figure 7: Dose-dependent stimulation of creatine kinase (CK)
speciﬁc activity by E2 in pituitary from immature female rats either
intact (solid line) or STZ-injected animals (dotted line). Rats were
treatedandassayedforCKactivityasdescribedinSection 2.R esults
are means ± SEM for n = 5 rats/group. Experimental means
compared to control means: ∗P<. 05 and ∗∗P<. 01. Basal activity
in Pi from immature intact rat was 0.86 + 0.04, and from STZ rats
was 0.78 +0.12 μmol/min/mg protein.
wasinducedfordiﬀerentextentsonlyinintactratsbutnotin
diabetic rats [23]. The response to E2 which was not induced
inthediabeticstatuswasnotseenevenwhenhigherdosesup
to 50μg/rat of E2 were used (Figure 7).
Eﬀects of Estradiol-17β with and without Vitamin D Less-
Calcemic Analogs on CK Speciﬁc Activity in Immature Female
Rats. When intact female rats were injected for 24 hours
with either E2 (at 0.5μg/rat or 5μg/rat) alone or with the
less- calcemic vitamin D analogs JKF or QW (0.2ng/gr
BW) or daily for 3 days with the analogs followed by
E2 for 24hours, all hormones induced CK when injected
alone; after pretreatment with JKF or QW the response to
E2 was up-regulated by about 50% (Figure 8). When rats
were injected with E2 at 0.5μg/rat, CK was up-regulated to
even higher extent, indicating not only up-regulation of the
response to E2 but also increased sensitivity (Figure 8).
Eﬀects of Estradio-17β with and without Vitamin D Less-
Calcemic Analogs for Diﬀerent Time Periods on CK Speciﬁc
Activity in Ovx Female Rats. When Ovx female rats were
injected daily for 3 days, 1 week or 10 weeks with the less-
calcemic vitamin D analogs JKF or QW (0.2ng/gr BW) and
then E2 (5μg / r a t )f o r2 4h o u r s ,C Kw a si n d u c e df o rd i ﬀerent
extent by the diﬀerent hormones. The response of the E2was
up-regulated by about 2 folds (Figure 9). The highest up-
regulation was noticed already after pretreatment for 3 days.
Eﬀects of Estradiol-17β Together with Raloxifene with and
without Vitamin D Less- Calcemic Analogs on CK Speciﬁc
Activity in Immature or Ovx Female Rats. Intact female rats
were injected for 24hours with either E2 (5μg/rat) or Ral
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Figure 8: The eﬀect of pretreatment with JKF and QW at 0.2ng/rat
for24hours(a)orfor3days(b)onCKactivityinPifromimmature
female rats compared to the stimulation of E2 at 0.5μg/rat or
5μg/rat and to the combination of the vitamin D analogs with E2.
Treatments were as described in Section 2. Results are expressed
as the ratios between the speciﬁc activities of CK in hormone-
treated and vehicle-injected control animals. The basal activity of
CK in was 0.86 + 0.14μmol/min/mg protein after 24hours and
0.92 + 0.18μmol/min/mg protein after 3 days, n = 5. ∗P<. 05,
∗∗P<. 01 in the diﬀerence compared to vehicle.
(500μg/rat), or E2 and Ral alone, or after daily injections
for 3 days with the less-calcemic vitamin D analogs JKF
or QW (0.2ng/gr BW). All hormones induced CK when
injected alone, but when E2 was injected together with Ral,
CK induced by E2 was inhibited. After pretreatment with
JKF or QW by daily injections for 3 days followed by E2,
Ral, or E2 + Ral, the response to E2 but not to Ral was up-
regulated by about 50%, but when injected together there
was no more inhibition of E2 by Ral (Figure 10(a)). When
Ovx female rats were pretreated similarly but for 1 week
instead of 3 days, similar results were obtained, but at higher
extent (Figure 10(b)).
4. Discussion
The key ﬁnding in the present study is that rat female
pituitary is a hormone-responsive organ which responds
at diﬀerent stages of development, to diﬀerent estrogenic
compounds similar to other rat organs such as the skeleton,
the uterus, and the vascular ones [29]. First, E2 as well
as diﬀerent phytoestrogens and their carboxy-derivatives
stimulate CK activity in rat pituitary of both immature
and Ovx similar to other estrogen-responsive organs such
as the skeleton and the vasculature ones, both by single6 International Journal of Cell Biology
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Figure 9: The eﬀect of pretreatment with JKF and QW at
0 . 2 n g / g / r a t / df o r1 0w e e k s( a ) ,1w e e k( b )o r3d a y s( c )o nC K
activity in Pi from OVX female rats compared to the stimulation of
E2 at 5μg/rat and to the combination of the vitamin D analogs and
E2. Treatments were as described in Section 2. Results are expressed
as the ratios between the speciﬁc activities of CK in hormone-
treated and vehicle-injected control animals. The basal activity of
CK in was 0.76 + 0.08μmol/min/mg protein, n = 5. ∗P<. 05,
∗∗P<. 01 in the diﬀerence compared to vehicle.
and long-term multiple injections [29]. Second, E2 as well
as diﬀerent phytoestrogens and their carboxy-derivatives
stimulate CK activity in rat pituitary of both immature and
Ovx similar to other estrogen-responsive organs such as the
skeleton and the vasculature. This response is inhibited by
the SERM Ral [29–31]. Third, all phytoestrogens-induced
CK were not signiﬁcantly aﬀected by addition of E2,e x c e p t
that of cG and cBA behaved like SERMs and inhibited E2
stimulated CK similar to other estrogen-responsive organs
such as the skeleton and the vasculature [32]. Fourth, the
less-calcemic analogs of vitamin D, JKF and QW, per se
increased CK in rat pituitary; moreover, pretreatment with
JKF or QW for diﬀerent time periods at both immature
and Ovx rats up-regulated the response and the sensitivity
to E2 similar to other estrogen-responsive organs such as
the skeleton and the vasculature [25, 30]. Fifth, licorice and
the phytoestrogens derived from it, that is, glabridin and
glabrene also stimulated rat pituitary CK activity from both
immature and Ovx rats, when applied for diﬀerent time
periods either by feeding or injections. This stimulation was
dose dependent. It is of interest to note that unlike Gla, Glb
was also SERM-like and inhibited E2 stimulated CK similar
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Figure 10: The eﬀect of pretreatment with JKF and QW at
0.2ng/g/rat/day for 3 days in immature female rats (a) or 1 week
in Ovx female rats (lower panel) on CK activity compared to the
stimulation by E2 at 5μg/rat or Ral at 500μg/rat or both, and to
the combination of the vitamin D analogs with E2,R a l ,o rb o t h .
Treatments were as described in Section 2. Results are expressed
as the ratios between the speciﬁc activities of CK in hormone-
treated and vehicle-injected control animals. The basal activity of
CK in was 0.78 + 0.10μmol/min/mg protein for Ovx and 1.02 +
0.12μmol/min/mg protein for immature female rats, n = 5. ∗P<
.05, ∗∗P<. 01, in the diﬀerence compared to vehicle.
to other estrogen-responsive organs such as the skeleton and
the vasculature [31]. Sixth, E2 failed to stimulate CK activity
in pituitary from diabetic immature and Ovx rats, even at
increased doses, similar to other estrogen-responsive organs
such as the skeleton and the vasculature [23].
PreviousstudiesshowedthatthestimulationofCKinthe
pituitary is similar to other rat organs, such as epiphysis and
diapyhsis in the skeleton as well as aorta and left ventricule
in the vasculature, but not in the uterus [30].
This is in accordance with other studies clearly demon-
strating that the pituitary is inﬂuenced by E2 in both
immature and Ovx rats, when other biological responses
such as hormonal secretion were determined [3]. This is
similar to other studies demonstrating the presence of ERs
in the rat pituitary, which are responding to E2 as well as
to phytoestrogens like revestranol [3]. Moreover phytoestro-
gens were found to inﬂuence also brain development, neural
function, and behavior parametrs [13].
The licorice derived phytoestrogens were previously
shown by us to have similar eﬀects on the skeleton and the
vasculature both in vivo and in vitro in cell derived systems
[11, 12, 27, 31].
The dietary estrogens exert biological activity and aﬀect
gonadotropin release from the pituitary [10]v i ab o t hE R α
and ERβ present in the rat pituitary [33], but the presentInternational Journal of Cell Biology 7
study is showing directly modulation of CK, which is an
estrogenic marker, in rat pituitary.
Vitamin D active metabolites have important physiolog-
ical eﬀects which are mediated via intracellular receptors
which are present in a variety of organs and tissues including
rat and human pituitary [34, 35]. Vitamin D also aﬀects
hormone secretions in the rat pituitary [36]. Moreover, E2
regulates vitamin D-mediated calcium absorption by the
induction of cytosolic calcium binding protein (CaBP-D9K)
[37] via ERs in the rat pituitary [38].
As previously shown in other organs [30], vitamin D
analogs up-regulate the response and the sensitivity of diﬀer-
ent rat organs from both immature and Ovx rats to E2 and to
diﬀerent phytoestrogens. In the present study, the pituitary
was shown to have similar properties, suggesting that there is
mutual modulation of this hormonal responsiveness in this
organ as well.
We have noticed that in diabetic rats the response to E2
of diﬀerent rat organs from both immature and Ovx rats was
abolished compared to intact rats [23]. In the present study,
the pituitary was shown to have similar properties, namely,
complete abolition of estrogenic response of rat pituitary
in the diabetic condition at both types of rats, even when
increased hormone levels were injected.
In conclusion, rat female pituitary is a hormone-
responsive organ which responds diﬀerently at diﬀerent
stages of development, to a variety of estrogenic compounds
similar to other rat organs such as the skeleton and the
vasculature but not the uterus. It is important to notice
that all compounds were eﬀective in using them at their
optimal dose. But in immature female rats E2 and G were
most eﬀective, and this small diﬀerence was not apparent
in Ovx female rats. Moreover it also responds to vitamin
D analogs alone and to their up-regulation properties.
These might suggest taking into consideration the response
of the pituitary in addition to the other organs, when
hormonal treatment, such as hormone replacement therapy
for postmenopausal women, is used for both its beneﬁcial
and hazardous aspects.
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